MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Bedside Assessment of Downgaze Palsy by Amplitude in Patients with Progressive Supranuclear Palsy

    T. Xie, M. Padmanaban, W. Abou Chaar, J. Nichols (Chicago, USA)

    Objective: To assess the specificity and reliability of the bedside assessment of downgaze palsy by amplitude based on the upper edge of the iris relative to…
  • 2024 International Congress

    String Vessel Formation Regionally Increases in Long Duration Parkinson’s Disease

    D. Dik, GM. Halliday, V. Sytnyk, C. Shepherd (Randwick, Australia)

    Objective: Parkinson's disease is a movement disorder characterised by α-synuclein deposition in the form of Lewy bodies and Lewy neurites. Vascular changes have been thought to contribute…
  • 2024 International Congress

    Establishing α-Synuclein Seeding Activity in Saliva as a Noninvasive Diagnostic Biomarker for Parkinson’s Disease

    Z. Wang, S. Gunzler, S. Chen, Q. Kong (Cleveland, USA)

    Objective: To establish α-synuclein seeding activity in saliva as a noninvasive diagnostic biomarker for Parkinson’s disease (PD). Background: PD is the second most common neurodegenerative…
  • 2024 International Congress

    Parkinson’s disease in a Special Population -Diagnosis and treatment of Parkinson’s disease in cases of psychiatric disorders treated with dopamine receptors antagonists-

    M. Nomoto, S. Oda, H. Doi (Imabari, Japan)

    Objective: We studied diagnosis and treatment of Parkinson’s disease in cases of psychiatric disorders treated with dopamine receptors antagonists for a long time. Background: Schizophrenia…
  • 2024 International Congress

    Impact of Striatal Degeneration on Patient Reported Symptoms in Idiopathic Normal Pressure Hydrocephalus

    Q. Hu, K. Badiola-Lim, D. Karimeddini, C-L. Kuo, N. Prakash (Farmington, USA)

    Objective: To compare the subjective presenting motor (MS) and nonmotor symptoms (NMS) in subjects with idiopathic normal pressure hydrocephalus (iNPH) with and without striatal degeneration…
  • 2024 International Congress

    24-Hour Ambulatory Blood Pressure Monitoring and Dipping Patterns in Parkinson’s Disease and Multiple System Atrophy

    D. Tunjungsari, M. Hildaria, I. Jeremia, A. Jody, C. Kathy, A. Tiksnadi (Central Jakarta, Indonesia)

    Objective: To depict 24-hour blood pressure profile, especially dipping patterns, in individuals diagnosed with Parkinson’s Disease (PD) and Multiple System Atrophy (MSA). Background: Both PD…
  • 2024 International Congress

    Cognitive Side Effects to Initial Levodopa Exposure as a “Red Flag”: A Retrospective Study

    A. Huang, A. Wise, V. Shanker (New York, USA)

    Objective: To assess if presence of cognitive side effects during an initial levodopa trial suggests the ultimate diagnosis of atypical Parkinson (APD) vs Parkinson disease…
  • 2024 International Congress

    Dual-Task Cost of Walking While Using a Smartphone: A Comparison Study of Older Adults with and Without Cognitive Decline

    G. Christofoletti, T. Lino, S. Sobrinho Junior (Campo Grande, Brazil)

    Objective: To investigate spatiotemporal gait parameters in older adults with and without cognitive decline while walking in the presence of smartphone use. Background: The use…
  • 2024 International Congress

    Cognitive function of patients with Parkinson´s Disease after Deep Brain Stimulation: a gene- and variant-based approach

    E. Asimakidou, G. Xiromerisiou, C. Sidiropoulos (Cambridge, United Kingdom)

    Objective: To investigate the cognitive outcomes of Deep Brain Stimulation (DBS) in conjunction with the genetic profile of Parkinson´s disease (PD) patients. Background: There are…
  • 2024 International Congress

    Detecting Mild Cognitive Impairment in Parkinson’s Disease using Speech Markers

    K. Smith, J. Williamson, T. Quatieri (Worcester, USA)

    Objective: To identify speech acoustic measures associated with mild cognitive impairment in PD (PD-MCI). Background: Detection of PD-MCI is a challenge for clinical care and…
  • « Previous Page
  • 1
  • …
  • 101
  • 102
  • 103
  • 104
  • 105
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley